Network News

Heidelberg, March 13, 2026 – Thursday, March 12, 2026, the boundaries of what is scientifically feasible and technically possible in cancer research were pushed further into the future: The approximately 130 participants at the GENESIS 26 – The LIFE SCIENCE TECH DAY forum hosted by InnovationLab GmbH did not merely content themselves with the scientific […]

We are pleased to introduce these new members and highlight the diverse capabilities they bring to our cluster! Looking forward to your active participation! Bioneer A/Shttps://bioneer.dk/Bioneer is an R&D-driven CRO and CDMO and a Danish government-approved RTO with 40 years of experience. The company supports biotech and pharma partners in drug discovery, early development, and […]

Prof. Dr. Gudrun Rappold, senior professor at Heidelberg University’s Medical Faculty, has been awarded the Medal of Honor by the German Society for Human Genetics. The Medal of Honor is the highest award given by the professional association and recognizes outstanding scientific achievements in human genetics as well as special contributions to the advancement of […]

The Hector Foundation is providing €1.3 million in funding for an interdisciplinary research project investigating the cardiological side effects of checkpoint inhibitors. The consortium, with partners at Heidelberg University’s Medical Faculty, the German Cancer Research Center, the Max Delbrück Center in Berlin, and the University Medical Center Schleswig-Holstein in Kiel, is investigating why these cancer […]

The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]

Rector Frauke Melchior: “A fantastic joint effort led to success” Heidelberg University has been successful in all previous rounds of the excellence competition and, in the current funding round, has convincingly defended its status as a University of Excellence. That announcement came today (Wednesday, 11 March 2026) from the German Science and Humanities Council and […]

How can the risk of failure in the development of drug compounds be reduced? In a recent paper, researchers at the NMI present a newly developed framework that makes the development of drug compounds from so-called single-domain antibodies (sdAb) safer and more reliable. Until now, drug development has generally proceeded as follows: one starts with […]

[Munich, 10/03/2026] — FGK Clinical Research GmbH, a leading full-service Contract Research Organization (CRO) headquartered in Germany, is thrilled to announce the further expansion of its operative team in the Netherlands. This strategic regional expansion strengthens FGK’s European presence and commitment to high-quality clinical research services. The local Dutch team will support clinical studies in the […]

Ladenburg, Germany, 9 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), announced on 7 March an additional amendment to its existing royalty purchase agreement with HealthCare Royalty (HCRx) and the participation of Soleus Capital Management, L.P. (Soleus Capital), a US-based life sciences investment firm, on behalf […]